Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G McLeod

Cancer

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancer|February 1, 1993
Antiandrogenic drugsD G McLeod
Cancer|June 1, 1979
Anaplastic seminoma: an analysis of 77 patientsB Percarpio, J C Clements, D G McLeod, et al.
Cancer|July 1, 1992
Controversies in the treatment of metastatic prostate cancerD G McLeod, E D Crawford, B A Blumenstein, et al.
Cancer|May 1, 1996
Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers?C L Bennett, D Matchar, D McCrory, et al.
Cancer|June 15, 1984
Intracranial metastases in prostate cancerH G Taylor, M Lefkowitz, S J Skoog, et al.
Cancer|July 1, 1988
Clinical predictors of response in metastatic germ cell tumorsG Taylor, D J Perry, R D Knight, et al.
Cancer|March 15, 1988
Extragonadal germ cell tumors. Clinicopathologic findings and treatment experience in 12 patientsD G McLeod, H G Taylor, S J Skoog, et al.
Cancer|December 15, 1993
The use of flutamide in hormone-refractory metastatic prostate cancerD G McLeod, R C Benson, M A Eisenberger, et al.
Cancer|March 1, 1997
Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomyJ J Bauer, R R Connelly, I A Sesterhenn, et al.
Cancer|January 1, 1992
A pilot trial of chemohormonal therapy for metastatic prostate carcinomaN A Dawson, G Wilding, R B Weiss, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer|February 1, 1993
Antiandrogenic drugsD G McLeod
Cancer|June 1, 1979
Anaplastic seminoma: an analysis of 77 patientsB Percarpio, J C Clements, D G McLeod, et al.
Cancer|July 1, 1992
Controversies in the treatment of metastatic prostate cancerD G McLeod, E D Crawford, B A Blumenstein, et al.
Cancer|May 1, 1996
Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers?C L Bennett, D Matchar, D McCrory, et al.
Cancer|June 15, 1984
Intracranial metastases in prostate cancerH G Taylor, M Lefkowitz, S J Skoog, et al.
Cancer|July 1, 1988
Clinical predictors of response in metastatic germ cell tumorsG Taylor, D J Perry, R D Knight, et al.
Cancer|March 15, 1988
Extragonadal germ cell tumors. Clinicopathologic findings and treatment experience in 12 patientsD G McLeod, H G Taylor, S J Skoog, et al.
Cancer|December 15, 1993
The use of flutamide in hormone-refractory metastatic prostate cancerD G McLeod, R C Benson, M A Eisenberger, et al.
Cancer|March 1, 1997
Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomyJ J Bauer, R R Connelly, I A Sesterhenn, et al.
Cancer|January 1, 1992
A pilot trial of chemohormonal therapy for metastatic prostate carcinomaN A Dawson, G Wilding, R B Weiss, et al.
Pageof 2